Viscosupplementation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

Description

Persistence Market Research has recently released a comprehensive report on the global visco-supplementation market. This report provides an in-depth evaluation of key market dynamics, including drivers, trends, opportunities, and challenges, delivering detailed insights into the market structure.

Key Insights:

Visco-supplementation Market Size (2024E): USD 5.9 Billion
Projected Market Value (2033F): USD 13.6 Billion
Global Market Growth Rate (CAGR 2024 to 2033): 9.7%

Visco-supplementation Market - Report Scope:

Visco-supplementation involves the injection of hyaluronic acid or other viscosupplements into the joints to provide lubrication and relieve pain, commonly used in the treatment of osteoarthritis. The market includes various product types, such as single-injection and multi-injection viscosupplements, and caters to hospitals, orthopedic clinics, and specialized treatment centers. Market growth is driven by the increasing prevalence of osteoarthritis, rising geriatric population, and advancements in viscosupplement technology, enhancing treatment efficacy and patient outcomes.

Market Growth Drivers:

The global visco-supplementation market is driven by several key factors, including the growing incidence of osteoarthritis, which necessitates effective management solutions. The increasing awareness of non-surgical treatment options, coupled with the rising geriatric population prone to joint disorders, further propels market growth. Technological advancements, such as the development of improved viscosupplement formulations and delivery systems, offer enhanced efficacy and patient comfort. Additionally, the expanding application of viscosupplementation in other joint disorders and rising healthcare investments support market expansion.

Market Restraints:

Despite its promising growth potential, the visco-supplementation market faces challenges related to high treatment costs and limited reimbursement coverage. The expense associated with viscosupplement injections can be a barrier to access, particularly in regions with constrained healthcare budgets. Furthermore, concerns regarding the long-term safety and effectiveness of viscosupplementation treatments and the potential for adverse reactions may impact market growth. Addressing these issues requires efforts to improve cost-effectiveness and ensure comprehensive safety assessments.

Market Opportunities:

The visco-supplementation market presents significant opportunities driven by technological advancements, demographic shifts, and evolving healthcare models. Innovations in viscosupplement products, such as enhanced formulations and extended-release systems, create new growth avenues. Additionally, the increasing adoption of minimally invasive procedures and advancements in regenerative medicine offer promising prospects for market players. Strategic collaborations, investment in research and development, and the introduction of cost-effective solutions are crucial to capitalizing on emerging opportunities and maintaining market competitiveness.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the visco-supplementation market globally?
Which types of viscosupplement products are gaining traction across various healthcare settings?
How are technological advancements influencing the competitive landscape of the visco-supplementation market?
Who are the key players in the visco-supplementation market, and what strategies are they employing to sustain market relevance?
What are the emerging trends and future prospects in the global visco-supplementation market?

Competitive Intelligence and Business Strategy:

Leading players in the global visco-supplementation market, including Allergan, Anika Therapeutics, and Seikagaku Corporation, focus on innovation, product differentiation, and strategic partnerships to secure a competitive edge. These companies invest in R&D to develop advanced viscosupplement products, such as novel hyaluronic acid formulations and enhanced delivery systems. Collaborations with healthcare providers and distributors facilitate market access and promote technology adoption. Additionally, emphasis on clinical research, evidence-based practice, and patient education supports market growth and improves treatment outcomes in the evolving visco-supplementation landscape.

Key Companies Profiled:

Allergan
Anika Therapeutics
Seikagaku Corporation
Revive Therapeutics
Mylan N.V.
Ferring Pharmaceuticals
BioRestorative Therapies
OrthogenRx Inc.
Celgene Corporation
Merz Pharmaceuticals

Market Segments Covered in Viscosupplementation Market Industry Analysis

By Product Type

Single Injection
Three Injection
Five Injection

By End User

Hospitals
Orthopaedic Clinics/Ambulatory Surgical Centres (ASCs)

Product Code: PMRREP33245

1. Executive Summary

1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

3.1. Risk Assessment
- 3.1.1. COVID-19 Crisis and Impact on Viscosupplementation Demand
- 3.1.2. COVID-19 Impact Benchmark with Previous Crisis
- 3.1.3. Impact on Market Value (US$ Bn)
- 3.1.4. Assessment by Key Countries
- 3.1.5. Assessment by Key Market Segments
- 3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends

4. Market Background and Foundation Data Points

4.1. Global Viscosupplementation Market (US$ Bn)
4.2. Viscosupplementation Market Opportunity Assessment (US$ Bn)
- 4.2.1. Total Available Market
- 4.2.2. Serviceable Addressable Market
- 4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
- 4.3.1. Demand in optimistic Scenario
- 4.3.2. Demand in Likely Scenario
- 4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
- 4.4.1. Investment in Established Markets
  - 4.4.1.1. In Short Term
  - 4.4.1.2. In Long Term
- 4.4.2. Investment in Emerging Markets
  - 4.4.2.1. In Short Term
  - 4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
- 4.5.1. Top Companies Historical Growth
- 4.5.2. Global Viscosupplementation Market Growth
- 4.5.3. District Cooling Adoption Rate, By Country
4.6. Market Dynamics
- 4.6.1. Market Driving Factors and Impact Assessment
- 4.6.2. Prominent Market Challenges and Impact Assessment
- 4.6.3. Viscosupplementation Market Opportunities
- 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

5.1. Manufacturers' Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking

6. Global Viscosupplementation Market Demand Analysis 2019-2023 and Forecast, 2024-2033

6.1. Historical Market Analysis, 2019-2023
6.2. Current and Future Market Projections, 2024-2033
6.3. Y-o-Y Growth Trend Analysis

7. Global Viscosupplementation Market Value Analysis 2019-2023 and Forecast, 2024-2033

7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033, By Product Type

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product Type, 2024-2033
- 8.3.1. Single Injection
- 8.3.2. Three Injection
- 8.3.3. Five Injection
8.4. Market Attractiveness Analysis By Product Type

9. Global Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033, By End User

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
- 9.3.1. Hospitals
- 9.3.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)
9.4. Market Attractiveness Analysis By End User

10. Global Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033, By Region

10.1. Introduction
10.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
10.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2024-2033
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. Asia Pacific
- 10.3.5. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region

11. North America Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033

11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
11.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
- 11.4.1. By Country
  - 11.4.1.1. U.S.
  - 11.4.1.2. Canada
  - 11.4.1.3. Rest of North America
- 11.4.2. By Product Type
- 11.4.3. By End User
11.5. Market Attractiveness Analysis
- 11.5.1. By Country
- 11.5.2. By Product Type
- 11.5.3. By End User

12. Latin America Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033

12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
12.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
- 12.4.1. By Country
  - 12.4.1.1. Brazil
  - 12.4.1.2. Mexico
  - 12.4.1.3. Rest of Latin America
- 12.4.2. By Product Type
- 12.4.3. By End User
12.5. Market Attractiveness Analysis
- 12.5.1. By Country
- 12.5.2. By Product Type
- 12.5.3. By End User

13. Europe Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033

13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
13.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
- 13.4.1. By Country
  - 13.4.1.1. Germany
  - 13.4.1.2. France
  - 13.4.1.3. U.K.
  - 13.4.1.4. Italy
  - 13.4.1.5. Benelux
  - 13.4.1.6. Nordic Countries
  - 13.4.1.7. Rest of Europe
- 13.4.2. By Product Type
- 13.4.3. By End User
13.5. Market Attractiveness Analysis
- 13.5.1. By Country
- 13.5.2. By Product Type
- 13.5.3. By End User

14. Asia Pacific Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033

14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
14.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
- 14.4.1. By Country
  - 14.4.1.1. China
  - 14.4.1.2. Japan
  - 14.4.1.3. South Korea
  - 14.4.1.4. Rest of Asia Pacific
- 14.4.2. By Product Type
- 14.4.3. By End User
14.5. Market Attractiveness Analysis
- 14.5.1. By Country
- 14.5.2. By Product Type
- 14.5.3. By End User

15. Middle East and Africa Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033

15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
15.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
- 15.4.1. By Country
  - 15.4.1.1. GCC Countries
  - 15.4.1.2. South Africa
  - 15.4.1.3. Turkey
  - 15.4.1.4. Rest of Middle East and Africa
- 15.4.2. By Product Type
- 15.4.3. By End User
15.5. Market Attractiveness Analysis
- 15.5.1. By Country
- 15.5.2. By Product Type
- 15.5.3. By End User

16. Key Countries Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033

16.1. Introduction
- 16.1.1. Market Value Proportion Analysis, By Key Countries
- 16.1.2. Global Vs. Country Growth Comparison
16.2. US Viscosupplementation Market Analysis
- 16.2.1. Value Proportion Analysis by Market Taxonomy
- 16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
  - 16.2.2.1. By Product Type
  - 16.2.2.2. By End User
16.3. Canada Viscosupplementation Market Analysis
- 16.3.1. Value Proportion Analysis by Market Taxonomy
- 16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
  - 16.3.2.1. By Product Type
  - 16.3.2.2. By End User
16.4. Mexico Viscosupplementation Market Analysis
- 16.4.1. Value Proportion Analysis by Market Taxonomy
- 16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
  - 16.4.2.1. By Product Type
  - 16.4.2.2. By End User
16.5. Brazil Viscosupplementation Market Analysis
- 16.5.1. Value Proportion Analysis by Market Taxonomy
- 16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
  - 16.5.2.1. By Product Type
  - 16.5.2.2. By End User
16.6. Germany Viscosupplementation Market Analysis
- 16.6.1. Value Proportion Analysis by Market Taxonomy
- 16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
  - 16.6.2.1. By Product Type
  - 16.6.2.2. By End User
16.7. France Viscosupplementation Market Analysis
- 16.7.1. Value Proportion Analysis by Market Taxonomy
- 16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
  - 16.7.2.1. By Product Type
  - 16.7.2.2. By End User
16.8. Italy Viscosupplementation Market Analysis
- 16.8.1. Value Proportion Analysis by Market Taxonomy
- 16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
  - 16.8.2.1. By Product Type
  - 16.8.2.2. By End User
16.9. BENELUX Viscosupplementation Market Analysis
- 16.9.1. Value Proportion Analysis by Market Taxonomy
- 16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
  - 16.9.2.1. By Product Type
  - 16.9.2.2. By End User
16.10. UK Viscosupplementation Market Analysis
- 16.10.1. Value Proportion Analysis by Market Taxonomy
- 16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
  - 16.10.2.1. By Product Type
  - 16.10.2.2. By End User
16.11. Nordic Countries Viscosupplementation Market Analysis
- 16.11.1. Value Proportion Analysis by Market Taxonomy
- 16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
  - 16.11.2.1. By Product Type
  - 16.11.2.2. By End User
16.12. China Viscosupplementation Market Analysis
- 16.12.1. Value Proportion Analysis by Market Taxonomy
- 16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
  - 16.12.2.1. By Product Type
  - 16.12.2.2. By End User
16.13. Japan Viscosupplementation Market Analysis
- 16.13.1. Value Proportion Analysis by Market Taxonomy
- 16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
  - 16.13.2.1. By Product Type
  - 16.13.2.2. By End User
16.14. South Korea Viscosupplementation Market Analysis
- 16.14.1. Value Proportion Analysis by Market Taxonomy
- 16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
  - 16.14.2.1. By Product Type
  - 16.14.2.2. By End User
16.15. GCC Countries Viscosupplementation Market Analysis
- 16.15.1. Value Proportion Analysis by Market Taxonomy
- 16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
  - 16.15.2.1. By Product Type
  - 16.15.2.2. By End User
16.16. South Africa Viscosupplementation Market Analysis
- 16.16.1. Value Proportion Analysis by Market Taxonomy
- 16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
  - 16.16.2.1. By Product Type
  - 16.16.2.2. By End User
16.17. Turkey Viscosupplementation Market Analysis
- 16.17.1. Value Proportion Analysis by Market Taxonomy
- 16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
  - 16.17.2.1. By Product Type
  - 16.17.2.2. By End User
- 16.17.3. Competition Landscape and Player Concentration in the Country

17. Market Structure Analysis

17.1. Market Analysis by Tier of Companies
17.2. Market Concentration
17.3. Market Share Analysis of Top Players
17.4. Market Presence Analysis
- 17.4.1. By Regional footprint of Players
- 17.4.2. Product footprint by Players

18. Competition Analysis

18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Competition Deep Dive
- 18.3.1. Sanofi
  - 18.3.1.1. Overview
  - 18.3.1.2. Product Portfolio
  - 18.3.1.3. Sales Footprint
  - 18.3.1.4. Strategy Overview
- 18.3.2. Anika Therapeutics, Inc.
  - 18.3.2.1. Overview
  - 18.3.2.2. Product Portfolio
  - 18.3.2.3. Sales Footprint
  - 18.3.2.4. Strategy Overview
- 18.3.3. SEIKAGAKU CORPORATION
  - 18.3.3.1. Overview
  - 18.3.3.2. Product Portfolio
  - 18.3.3.3. Sales Footprint
  - 18.3.3.4. Strategy Overview
- 18.3.4. Zimmer Biomet
  - 18.3.4.1. Overview
  - 18.3.4.2. Product Portfolio
  - 18.3.4.3. Sales Footprint
  - 18.3.4.4. Strategy Overview
- 18.3.5. Smith & Nephew PLC
  - 18.3.5.1. Overview
  - 18.3.5.2. Product Portfolio
  - 18.3.5.3. Sales Footprint
  - 18.3.5.4. Strategy Overview
- 18.3.6. Ferring Pharmaceutical B.V.
  - 18.3.6.1. Overview
  - 18.3.6.2. Product Portfolio
  - 18.3.6.3. Sales Footprint
  - 18.3.6.4. Strategy Overview
- 18.3.7. Lifecore Biomedical, LLC (Landec)
  - 18.3.7.1. Overview
  - 18.3.7.2. Product Portfolio
  - 18.3.7.3. Sales Footprint
  - 18.3.7.4. Strategy Overview
- 18.3.8. LG Life Sciences Ltd.
  - 18.3.8.1. Overview
  - 18.3.8.2. Product Portfolio
  - 18.3.8.3. Sales Footprint
  - 18.3.8.4. Strategy Overview
- 18.3.9. Fidia Farmaceutici S.p.A
  - 18.3.9.1. Overview
  - 18.3.9.2. Product Portfolio
  - 18.3.9.3. Sales Footprint
  - 18.3.9.4. Strategy Overview
- 18.3.10. F.Hoffmann-La Roche Ltd.
  - 18.3.10.1. Overview
  - 18.3.10.2. Product Portfolio
  - 18.3.10.3. Sales Footprint
  - 18.3.10.4. Strategy Overview